Search - tctmd.com

Displaying 541 - 560 of 1548

Sort: Relevancy | Date

News Conference News EuroPCR 2019

Endocarditis After TAVR: Real-world Data Speak to Its Rarity but Also the ‘Devastating’ Impact

Caitlin E. Cox

June 07, 2019

News Conference News SCAI 2019

ProGlide Comes Out Ahead of Prostar in Vascular Closure After Transfemoral TAVR: BRAVO 3

Yael L. Maxwell

June 05, 2019

News Conference News SCAI 2019

TAVR Operators: Can One Do It All or Are Two Still Justified?

Yael L. Maxwell

June 04, 2019

News Conference News SCAI 2019

Early Bird Bleed Monitoring System Shows Promise in Endovascular Procedures

Yael L. Maxwell

May 31, 2019

News Daily News

Terumo’s Solopath Transfemoral System and Recollapsible Balloon Access System Recalled for Dislodging Issues

L.A. McKeown

May 30, 2019

News Conference News EuroPCR 2019

Allegra TAVR System Feasible for Treating Degenerated Surgical Valves

Michael O'Riordan

May 29, 2019

CHOICE: Better Hemodynamics, Less Structural Deterioration with CoreValve

News Conference News EuroPCR 2019

Self-Expanding vs Balloon-Expandable TAVR? Some Insights From CHOICE

Michael O'Riordan

May 24, 2019

News Conference News EuroPCR 2019

TAVR’s Benefit Across ‘Spectrum of Risk’ Supports Paradigm Shifts, Says EuroPCR Statement

Shelley Wood

May 23, 2019

News Conference News EuroPCR 2019

Valve Leaflet Scoring Device for Aortic Stenosis Clears Feasibility Hurdle

Michael O'Riordan

May 23, 2019

News Conference News EuroPCR 2019

Longer Follow-up ‘Reassuring’ for New-Onset LBBB After TAVR—With Caveats

Michael O'Riordan

May 22, 2019

News Conference News HRS 2019

PRAGUE-12: Surgical Ablation of A-fib During Cardiac Surgery Has Long-term Stroke Benefit

Todd Neale

May 20, 2019

News Conference News EuroPCR 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Shelley Wood

May 16, 2019

News Industry News

BioTrace Medical’s Tempo Lead Obtains CE Mark for Safe and Secure Temporary Intracardiac Pacing

May 08, 2019

News Industry News

Pi-Cardia Successfully Completes First-in-Human Studies with Novel Non-implant Based Treatment of Aortic Stenosis

May 07, 2019

News Daily News

Public Comments Largely Supportive of CMS Plan for TAVR, With Some Suggested Tweaks

Todd Neale

May 01, 2019

News Daily News

Women Have Higher Risk of TAVR-Related Pericardial Complications

Todd Neale

April 26, 2019

News Daily News

FDA Approves Lotus Edge, Ushering Third Device Into US Market

Shelley Wood

April 24, 2019

News Industry News

Boston Scientific Receives FDA Approval for LOTUS Edge™ Aortic Valve System

April 23, 2019

News Daily News

Multisociety Consensus Statement Tackles the Classification of Heart Valve Centers

L.A. McKeown

April 19, 2019

News Daily News

Continuing Anticoagulation During TAVR: New Data Offer a Glimpse of What Works

Shelley Wood

April 16, 2019

Advertisement

Endocarditis After TAVR: Real-world Data Speak to Its Rarity but Also the ‘Devastating’ Impact

ProGlide Comes Out Ahead of Prostar in Vascular Closure After Transfemoral TAVR: BRAVO 3

TAVR Operators: Can One Do It All or Are Two Still Justified?

Early Bird Bleed Monitoring System Shows Promise in Endovascular Procedures

Terumo’s Solopath Transfemoral System and Recollapsible Balloon Access System Recalled for Dislodging Issues

Allegra TAVR System Feasible for Treating Degenerated Surgical Valves

Self-Expanding vs Balloon-Expandable TAVR? Some Insights From CHOICE

TAVR’s Benefit Across ‘Spectrum of Risk’ Supports Paradigm Shifts, Says EuroPCR Statement

Valve Leaflet Scoring Device for Aortic Stenosis Clears Feasibility Hurdle

Longer Follow-up ‘Reassuring’ for New-Onset LBBB After TAVR—With Caveats

PRAGUE-12: Surgical Ablation of A-fib During Cardiac Surgery Has Long-term Stroke Benefit

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

BioTrace Medical’s Tempo Lead Obtains CE Mark for Safe and Secure Temporary Intracardiac Pacing

Pi-Cardia Successfully Completes First-in-Human Studies with Novel Non-implant Based Treatment of Aortic Stenosis

Public Comments Largely Supportive of CMS Plan for TAVR, With Some Suggested Tweaks

Women Have Higher Risk of TAVR-Related Pericardial Complications

FDA Approves Lotus Edge, Ushering Third Device Into US Market

Boston Scientific Receives FDA Approval for LOTUS Edge™ Aortic Valve System

Multisociety Consensus Statement Tackles the Classification of Heart Valve Centers

Continuing Anticoagulation During TAVR: New Data Offer a Glimpse of What Works

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content